Oxford Bioscience Partners

edit

Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stage situations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.

Milestones

edit

• 
  Oxford Bioscience Partners invested in Cambrios Technologies. (11/09)
  Posted 11/9/09 at 1:36am
• 
  Oxford Bioscience Partners invested in Coherex Medical. (10/12/09)
  Posted 10/12/09 at 6:12pm
• 
  Oxford Bioscience Partners invested in VaxInnate. (6/14/09)
  Posted 6/16/09 at 8:28am
• 
  Oxford Bioscience Partners invested in Elixir Pharmaceuticals. (5/27/09)
  Posted 6/17/09 at 1:38pm
• 
  Oxford Bioscience Partners invested in Claros Diagnostics. (3/23/09)
  Posted 3/23/09 at 9:54am
• 
  Oxford Bioscience Partners invested in CircuLite. (3/11/09)
  Posted 3/11/09 at 9:44am
• 
  Oxford Bioscience Partners invested in Seahorse Bioscience. (3/9/09)
  Posted 6/20/09 at 12:18am
• 
  Oxford Bioscience Partners invested in Pathway Medical Technologies. (3/09)
  Posted 4/13/09 at 1:51pm
• 
  Oxford Bioscience Partners invested in Rib-X Pharmaceuticals. (1/25/09)
  Posted 4/17/09 at 8:17am
• 
  Oxford Bioscience Partners invested in Luca Technologies. (12/23/08)
  Posted 6/22/09 at 11:21am
• 
  Oxford Bioscience Partners invested in BrainCells. (3/08)
  Posted 5/22/09 at 10:38am
• 
  Oxford Bioscience Partners invested in Laboratory Partners. (1/14/08)
  Posted 9/17/09 at 7:44am
• 
  Oxford Bioscience Partners invested in Intechra Holdings. (5/23/07)
  Posted 9/11/09 at 11:57pm
• 
  Oxford Bioscience Partners invested in Elixir Pharmaceuticals. (11/29/06)
  Posted 6/19/09 at 10:13am
• 
  Oxford Bioscience Partners invested in Cambrios Technologies. (2/1/05)
  Posted 11/9/09 at 11:29am

Investments

Videos

Sources

1. Cambrios lands $14.5M for electronic display components (deals.venturebeat.com) [edit]
2. Coherex Medical, Inc.: Series B $16.5M (onbiovc.com) [edit]
3. VaxInnate Corp., Series D $30M (onbiovc.com) [edit]
4. Elixir Pharmaceuticals, Inc.: Series D $12M (onbiovc.com) [edit]
5. Claros Diagnostics Raises $4 Million (pehub.com) [edit]
6. CircuLite Raising $33 Million Third Round (pehub.com) [edit]
7. Seahorse Bioscience lands $6M, buys BioProcessors Corp (masshightech.com) [edit]
8. Pathway Medical lands generous $40M to treat arterial disease (venturebeat.com) [edit]
9. Rib-X Pharmaceuticals Announces Positive Phase 2 Study Results for Delafloxacin and a $25 Million Financing (rib-x.com) [edit]
10. Luca Technologies Raises $76M for Coal Biotech (earth2tech.com) [edit]
11. BrainCells raises $30M (venturebeat.com) [edit]
12. Clinical diagnostics maker Laboratory Partners pulls in $16M (deals.venturebeat.com) [edit]
13. Intechra, electronics recycler, gets $30M (deals.venturebeat.com) [edit]
14. Elixir raises $46M for fountain of youth (deals.venturebeat.com) [edit]
15. Cambrios (cambrios.com) [edit]